发明名称 USE OF PROSTATE SPECIFIC ANTIGEN TO PREDICT DRUG RESPONSE
摘要 A method of determining the likelihood for a subject to respond to a drug, comprising: measuring at least one PSA-related value in a subject suffering from a PSA-related disorder and having been administered a drug for treating the PSA-related disorder; comparing the PSA-related value with its respective control value; and determining the likelihood for the subject to respond to the drug, wherein the PSA- related value is selected from the group consisting of the amount of BPSA, the amount of proPSA, the ratio of BPSA to proPSA, the ratio of BPSA to total PSA, the ratio of BPSA to free PSA, and a combination thereof; and wherein the amount of BPSA, the ratio of BPSA to proPSA, the ratio of BPSA to total PSA or the ratio of BPSA to free PSA, if higher than its respective control value by a respective first predetermined value; the amount of proPSA, if lower than its respective control value by a second predetermined value; or a combination thereof; indicates that the subject is likely responsive to the drug. Also disclosed is a kit for using such a method to predict whether a subject would be a drug responder.
申请公布号 WO2006094223(A3) 申请公布日期 2009.04.16
申请号 WO2006US07709 申请日期 2006.03.02
申请人 HYBRITECH INCORPORATED;MIKOLAJCZYK, STEPHEN, D. 发明人 MIKOLAJCZYK, STEPHEN, D.
分类号 G01N33/574 主分类号 G01N33/574
代理机构 代理人
主权项
地址